Advertisement

Epidemiologie, Ätiologie und Klassifikation des Harnblasenkarzinoms

  • Frank vom Dorp

Zusammenfassung

Das Harnblasenkarzinom repräsentiert eine der häufigsten onkologischen Erkrankungen weltweit. 130.000 Menschen versterben jährlich weltweit an einem Harnblasenkarzinom. Männer erkranken doppelt so häufig wie Frauen, wobei das mittlere Erkrankungsalter bei 69 Jahren für Männer und bei 73,4 Jahren bei Frauen liegt. Zahlreiche kanzerogene Substanzen sind identifiziert worden, deren Exposition ursächlich mit der Entstehung des Harnblasenkarzinoms vergesellschaftet ist. Allen voran ist der Zigarettenkonsum zu nennen, gefolgt von aromatischen Aminen, deren Exposition zum Teil beruflich bedingt ist. Die Strahlentherapie kann ursächlich sein für die Entstehung von Sekundärmalignomen, unter anderem können Harnblasenkarzinome entstehen.

Literatur

  1. Aghaji AE, Mbonu OO (1989) Bladder tumors in Enugu, Nigeria. Br J Urol 64:399Google Scholar
  2. Anderström C, Johansson SL, van Schulz L (1983) Primary adenocarcinoma of urinary bladder. Cancer 52:1273Google Scholar
  3. Babaya K, Takahashi S, Momose H et al. (1987) Effects of single chemotherapeutic agents in development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats. Urol Res 15: 329–334Google Scholar
  4. Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger TA (1987) Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-result follow-up study. Am J Med; 83:1–9Google Scholar
  5. Bedwani R, Renganathan E, El Kwhsky F et al. (1998) Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77 (7):1186–1189Google Scholar
  6. Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, et al.(2000) Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer.; 86:289–294Google Scholar
  7. Case RAM, Pearson JT (1954) Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part II: Further consideration of the role of aniline and of the manufacture of auramine and magenta (fuchsine) as possible causative agents. Br J Ind Med 11:213Google Scholar
  8. Cole P (1971) Coffee-drinking and cancer of the lower urinary tract. Lancet I:1335Google Scholar
  9. Coleman M, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, Knerer G, Pitard A, Quinn M, Scoggett A, De Stavoua B (1999) Cancer Survival Trends in England and Wales, 1971–1995 : Deprivation and NHS Region. London: The Stationary OfficeGoogle Scholar
  10. Dalbagni G, Vora K, Kaag M, Cronin A, Bochner B, Donat SM, Herr HW (2009) Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol 56:903-910Google Scholar
  11. Deutz FJ, Rübben H, Küpper W, Hofstädter F (1988) Morphologie der Harnblase und des Darms nach Harnleiter-Sigmaimplantation unter Karzinogenexposition. 9. Symposium Experimentelle Urologie. Aachen, 16.–18.6Google Scholar
  12. Donato F, Boffetta P, Fazioli R, Gelatti U, Porru S (1998) Reliability of data on smoking habit and coffee drinking collected by personal interview in a hospital-based case-control study. Eur J Epidemiol 14 (3) :259–267Google Scholar
  13. Fairchild WV, Spence CR, Solomon HD, Gangai MP (1979) The incidence of bladder cancer after cyclophosphamide therapy. J Urol 122:163Google Scholar
  14. Gontero P, Sylvester R, Pisano F, Joniau S, Oderda M, Serretta V et al (2016) The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high grade / Grade 3 bladder cancer treated with bacilli- Calmette Guerin BJU Int 118:44-52Google Scholar
  15. Gonheim MA, Ashamallah AK, Awaad HK, Whitemore WF Jr (1985) Randomized trial with cystectomy with preoperative radiotherapy for carcinoma of the bilharzial bladder. J Urol 134:266Google Scholar
  16. Gonwa TA, Corbett WT, Schey HM, Buckalew VM (1980) Analgesic associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med 93:249Google Scholar
  17. Hecht SS, Tso TC, Hoffmann D (1976) Selective reduction of tumorgenicity of tobacco smoke. IV Approaches to the reduction of N-nitrosamines and aromatic amines. Proceedings of Third World Conference o smoking and health. Dept Health Education and Welfare Publ No (NIH) 76:535Google Scholar
  18. Hicks RM, Walters CL, El Sebai I, El Asser AB, El Merzabani M, Grough TA (1977) Demonstration of nitrosamines in human urine. Preliminary observations on a possible aetiology for bladder cancer in association with chronic urinary tract infection. Proc R Soc Med 70:413Google Scholar
  19. Hoffmann D, Masuda Y, Wynder EL (1969) Alpha-naphthylamine and beta-naphthylamine in cigarette smoke. Nature 221:254Google Scholar
  20. Hueper WC, Wiley FH, Wolfe HD (1938) Experimental production or bladder tumours in dogs by administration of beta-naphthylamine. J Indust Hyg Toxiol 20/1:46Google Scholar
  21. Irving CC, Murphy WM, Damil DS (1984) Comparative carinogenicity of N-Butyl-N-(3 carboxypropyl)-Nitrosamin and N-Butyl-N(4 hydroxybutyl) nitrosamine for the urinary bladder of (C5BL/6×DBA/2)F1 mice. JNCI 73/3:753–756Google Scholar
  22. Ito N (1984) Histogenesis of urinary bladder tumors induced by nitrosamine in rats. J Cancer Res Clin Oncol 108:169–173Google Scholar
  23. Ito N (1988) Early changes caused by nitrosamine in the bladder epithelium of different animal species. Jpn J Cancer Res 79 (4):413–417Google Scholar
  24. Jakse G, Jakobi GH, Altwein JE (1979) Das Adenokarzinom der Harnblase. Urologe A 18:86Google Scholar
  25. Johansson SL, Cohen SM. (1997) Epidemiology and etiology of bladder cancer. Semin Surg Oncol.; 13:291–298Google Scholar
  26. Johnson DE, Schoenwald MB, Ayala AG, Miller LS (1976) Sqamous cell carcinoma of the bladder. J Urol 115:542Google Scholar
  27. Kaufmann JM, Fam B, Jacobs SC, Gabrilondo F, Yalla S, Kane JP, Rossier AB (1977) Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol 118:967Google Scholar
  28. Kunze E, Calude J, Frentzel-Beyme R (1986) Associalion of cancer ot the lower urinary tract with consumption of alcoholic beverages — a case control study. Carcinogenesis 7:163Google Scholar
  29. Linn JFJ, Rübben H. (1995) Die Wirkung von Keyhole-Limpet-Haemocyanin auf chemisch induzierte Blasentumore bei Ratten. Vergleich subkutaner vs. intraversikaler Applikation vs. Kontrollgruppe. 12. Symposium für experimentelle Urologie. 18.03.95, BerlinGoogle Scholar
  30. Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, et al. (2000) Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol Biomarkers Prev. 9:461–467Google Scholar
  31. McCredie M, Stewart JH, Ford JM, McLennan RA (1983) Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol; 55: 220–224Google Scholar
  32. Micheli A, Mariotto A, Giorgio Rossi A, Gatta G, Muti P (1998) Eurocare Working Group, The prognostic role of gender in survival of adult cancer patients. Eur J Cancer; 14: 2271–2278Google Scholar
  33. Morrison AS, Cole P (1982) Urinary tract. In: Schottenfeld D, Fraumeni FJ, Saunders WB (eds) Cancer epidemiology and prevention. Saunders, Philadelphia, p. 925Google Scholar
  34. Mostafa MH, Helmi S, Badawi AF, Tricker AR, Spiegelhalder B, Preussmann R (1994) Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients. Carcinogenesis; 15: 619–625Google Scholar
  35. Norpoth K, Woitowitz HJ (1994) Beruflich verursachte Tumoren. Dt. Ärzte Verlag, Köln, S. 25–31Google Scholar
  36. Ohkawa T, Fujinaga T, Doi J, Ebisuno S, Takamatsu M, Nakamura J, Kido R (1982) Clinical study on occupational uroepithelial cancer in Wakayama City. J Urol 128:520Google Scholar
  37. Olsen CA, Vere White RW de (1979) Cancer of the bladder. In: Javadpour N (ed) Principles and management of urologic cancer. Williams & Wilkins, Baltimore, p.337Google Scholar
  38. Parkin DM, Bray F, Ferley J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer Oct 15,94(2):153–6Google Scholar
  39. Pashos CL, Botteman MF, Laskin BL, Redaelle A; Bladder cancer (2002) Epidemiology, Diagnosis and Management Cancer Practice Nov/Dec; 10 (6):311–322Google Scholar
  40. Patterson JM, Ray EH, Mendiondo OA, Medina WD, Gee WF (1988) A new treatment for invasive sqamous cell bladder cancer: the nigro regimen:preoperative chemotherapy and radiation therapy. J Urol 140:379Google Scholar
  41. Patrianakos C, Hoffmann D (1979) Chemical studies on tobacco smoke. LXIV On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 3:150Google Scholar
  42. Pearson RM, Soloway MS (1978) Does cyclophosphamide induce bladder cancer? Urology 4:437Google Scholar
  43. Pedersen-Bjergaard J, Ersboll J, Hansen VL et al. (1988); Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin lymphoma. N Engl J Med 318: 1028–1032Google Scholar
  44. Petkovic S, Multavdzik M, Petronic V, Marcovic V (1971) Tumours of the renal pelvis and ureter: clinical and aetiologic studies. J Urol Nephrol (Paris) 77:429Google Scholar
  45. Probert JL, Persad RA, Greenwood RP, Gillatt DA, Smith PJ (1998) Epidemiology of transitional cell carcinoma of the bladder: profile of an urban population in the south-west of England. Br J Urol 82 (5): 660–666Google Scholar
  46. Quilty PM, Duncan W (1986) Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int J Radiat Oncol Biol Phys 12:853Google Scholar
  47. Raghavan D, Huben R, (1995) Management of bladder cancer Curr Probl Cancer 19:1–64Google Scholar
  48. Riede UN, Schaefer HE (1995) Allgemeine und spezielle Pathologie. Georg Thieme Verlag, Stuttgart, New YorkGoogle Scholar
  49. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. (2000) SEER Cancer Statistics Review, 1973–1997. Bethesda, Md: National Cancer InstituteGoogle Scholar
  50. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK (eds) (1999) SEER Cancer Statistics Review, 1973-1996. Bethesda MD: National Cancer Institute. NIH; Pub. No. 99–2789Google Scholar
  51. Sadetzki S, Bensal D, Blumstein T, Novikov I, Modan B (2000) Selected risk factors for transitional cell bladder cancer. Med Oncol.; 17:179–182Google Scholar
  52. Schulte PA, Ringen K, Hemstreet GP (1986) Risk factors for bladder cancer in cohort exposed to aromatic amines, Cancer 58:2156Google Scholar
  53. Sen SE, Malek RS, Farrow GM, Lieber MM (1985) Sarcoma and carcinosarcoma of the bladder in adults. J Urol 133:29–30Google Scholar
  54. Sherif A, De la Torre M, Maömström PU et al. (2001) Lymphatic mapping and detection of sentinel nodes in patients with bladder cancer. J Urol 166:812–815Google Scholar
  55. Shibata MA et al. (1989) The role of BBN in F344 rats. J Toxicol Environ Health 26 (3):255–265Google Scholar
  56. Silverman DT, Hartge P, Morrison AS, Devesa SS (1992) Epidemiology of bladder cancer. Hematol Oncol Clin North Am 3:421–428Google Scholar
  57. Simon R, Bürger H, Brinkschmidt C, Böcker W, Hertle L, Terpe H (1998) Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol; 185:345–351Google Scholar
  58. Vineis P, Pirastu R (1997) Cancer Causes Control 8:346–355Google Scholar
  59. Wynder EL, Goldsmith R (1977) The epidemiology of bladder cancer: a second look. Cancer 40:1246Google Scholar
  60. Zeegers MPA, Kellen E, Buntinx, Brandt van den PA (2004) The association between smoking, beverage consumption, diet and bladder cancer: a systemic literature review. World J Urol 21:392–401Google Scholar
  61. Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ, Gasser TC, Sauter G (1999) Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res. 59: 4685–4661Google Scholar
  62. Zheng W, McLaughlin JK, Gao YT, Silverman DT, Gao RN, Blot WJ (1992) Bladder cancer and occupation in Shanghai, 1980-1984. Am J Ind Med. 21:877–885Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2018

Authors and Affiliations

  1. 1.Chefarzt der Urologischen Klinik Helios Marien KlinikumDuisburgDeutschland

Personalised recommendations